Inhibition of rho-kinase impairs fibroblast stress fiber formation, confluence, and contractility in vitro.
Rho kinase is an enzyme that has been implicated in pathological wound healing. In our study, we aimed to characterize the dosages of Y-27632 (a competitive inhibitor of rho kinase) at which fibroblast stress fiber formation is inhibited, to determine the effect of Y-27632 on fibroblast confluence, and to determine the effect of varying concentrations of Y-27632 on fibroblast-mediated gel contraction. First, 3T3 fibroblasts were exposed to various concentrations of Y-27632, and stress fiber dissolution was assessed with immunofluorescence. Next, 10 microM Y-27632 was applied to 3T3 fibroblast monolayer cultures immediately after plating and at 8 hours after plating to determine the effect on fibroblast confluence. Finally, a three-dimensional model was used to assess the effect of Y-27632 on gel contraction. Increasing doses of Y-27632 resulted in a dose-dependent increase in stress fiber dissolution as well as a dose-dependent inhibition of gel contraction. Median number of days to confluence were 3, 5, and 6 after no, immediate, and delayed incubation with Y-27632, respectively (P < .05). Our results further characterize the dosages at which Y-27632 may be most effective in the modulation of wound contraction in burn patients. In addition, our confluence study suggests that patients need not necessarily be pretreated with Y-27632.
Gates
Douglas H
DH
Department of Surgery, , The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7228, USA.
Lee
Jin Sun
JS
Hultman
C Scott
CS
Cairns
Bruce A
BA
D000199:Actins / Q000378:metabolism*; D000577:Amides; D000959:Antihypertensive Agents; D002056:Burns / Q000150:complications; D017439:Cicatrix, Hypertrophic / Q000503:physiopathology*; D003094:Collagen; D003286:Contracture / Q000503:physiopathology*; D005347:Fibroblasts / Q000502:physiology*; D005455:Fluorescent Antibody Technique; D066298:In Vitro Techniques; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors*; D008962:Models, Theoretical; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D011725:Pyridines; D022502:Stress Fibers; D014945:Wound Healing; D054460:rho-Associated Kinases
D000199:Actins; D000577:Amides; D000959:Antihypertensive Agents; D047908:Intracellular Signaling Peptides and Proteins; D011725:Pyridines; C108830:Y 27632; D003094:Collagen; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases